Today Michael Graber from the CARE Lab (carelab.at) completed his PhD Defensio with distinction! We are proud of him and his major contribution to shockwave therapy with regard to the transdifferentiation of cardiac fibroblasts to functional endothelial cells!

Check out this Article from JoVE in which we describe how to apply shockwaves in a murine model:
jove.com/video/62338

Shock Wave Therapy for the Ischemic Heart (J. Cooke, MD, L. Lai, PhD, J.... youtu.be/EkCKNFmBQFM via YouTube
Our PI was featured at Houston Methodist Hospitals DeBakey Cardiovascular Science Series talking about Cardiac Shockwave Therapy. Great show!

Happy to share our newest publication on the therapeutic range of cardiac shockwave therapy. A puzzle piece that was missing as an important argument especially with regard to our cardiac application.

nature.com/articles/s4159…

#HeartFailure #shockwave #regenerativemedicine

Happy to share our newest manuscript: The study protocol of the CAST-HF Trial was published in Trials.

trialsjournal.biomedcentral.com/articles/10.11…

cast-trial.com

#HeartFailure #shockwave #regeneration #heartsurgery

Our consortium on 'B-cells in Cardiovascular Disease'was selected by Foundation Leducq for their Transatlantic Networks of Excellence Program.
Excited to work with Fil Swirski & Scientists Ziad Mallat SMalin CMcNamara SPillai on novel #immunotherapy approaches for #CVD
👇
fondationleducq.org/transatlantic-…

Heart failure is ever increasing and a central topic at this years Cardiology Congress in Innsbruck. CAST-HF trial PI Johannes Holfeld gives a keynote lecture on surgical heart failure treatment.
#HeartFailure #Cardiology #HeartSurgeons

Medical University of Innsbruck featured our current research findings on cardiac shockwave therapy only recently on its website:

#shockwave #regeneration

Right in time to New Year's Eve 'Science Advances' published an article on shockwaves occurring during champagne cork popping! Cheers! 🥂

advances.sciencemag.org/content/advanc…

#shockwave #champagne

RT HeartRegen: keep it up! carelab.at twitter.com/CastTrial/stat…

carelab.at, the research group behind CAST-HF Trial is trying to get a new picture of its group members. See one preliminary example here from the rooftop shooting on the heliport of Med. Uni. Innsbruck.

Correct # is #HFA_ESC . Just for info Shelley Zieroth Mihai Trofenciuc SABOURETCardiologist Dr Anastasia Mihailidou FAHA FCSANZ FESC Harriette Van Spall, MD MPH @DrLadyMaria1 Ekaterini Lambrinou💙 Paola Morejón Barragán Julia Grapsa Marco Metra Zurich Heart House (ZHH) CHFS CCF

#RT @HeaRTRegen: RT CAST-HF Trial: Congratulations to Can Gollmann-Tepeköylü from the Cardiosurgical Research Lab at Med. Uni. Innsbruck (carelab.at) for winning a highly recognized Alumni Scientia Award! The laudatio was given by Gerd Silberhumer fro…

Congratulations to Can Gollmann-Tepeköylü from the Cardiosurgical Research Lab at Med. Uni. Innsbruck (carelab.at) for winning a highly recognized Alumni Scientia Award! The laudatio was given by Gerd Silberhumer from MedUni Wien. Can serves as a Co-I at the CAST-HF Trial

On Friday Gregor Holfeld, CFO of our industry partner @HeaRTRegen, presented the business case of cardiac shockwave therapy at the Tyrolean Chamber of Economics Wirtschaftskammer Österreich. The CAST-HF Trial has a huge socio-economic impact! #shockwave #heartregeneration #MedTech #medicine

Stoßwellentherapie nach Herzinfarkt: Vom Forschungslabor in die Klinik dlvr.it/R1k6ww

~570 US businesses offer #stemcell therapy, at least 61 of which market it to patients with #heartfailure . Since the treatment is not supported by evidence or approved by U.S. FDA, regulatory action needs to be directed to these unauthorized activities. ja.ma/2FuKJSx

These findings do not support the use of mesenchymal precursors in heart failure patients!
#heartfailure #heartregeneration #cardiovascular #shockwave